Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joannis E Vamvakopoulos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Drug Targets. Cardiovascular & Haematological Disorders|April 28, 2005
Three's company: regulation of cell fate by statinsJoannis E Vamvakopoulos
BMC Cardiovascular Disorders|July 23, 2003
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotectionJoannis E Vamvakopoulos, Colin Green
Journal of Vascular Research|May 26, 2005
A mouse model of aortic angioplasty for genomic studies of neointimal hyperplasiaLyubomir Petrov, Hanna Laurila, Pekka Hayry, et al.
The Annals of Pharmacotherapy|February 28, 2008
Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statinsJoannis E Vamvakopoulos, Melpomeni Kountouri, Tom Marshall, et al.
Journal of Vascular Research|January 18, 2006
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosisJoannis E Vamvakopoulos, Lyubomir Petrov, Silja Aavik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
Interleukin 1 and chronic rejection: possible genetic links in human heart allograftsJoannis E Vamvakopoulos, Craig J Taylor, Colin Green, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Drug Targets. Cardiovascular & Haematological Disorders|April 28, 2005
Three's company: regulation of cell fate by statinsJoannis E Vamvakopoulos
BMC Cardiovascular Disorders|July 23, 2003
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotectionJoannis E Vamvakopoulos, Colin Green
Journal of Vascular Research|May 26, 2005
A mouse model of aortic angioplasty for genomic studies of neointimal hyperplasiaLyubomir Petrov, Hanna Laurila, Pekka Hayry, et al.
The Annals of Pharmacotherapy|February 28, 2008
Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statinsJoannis E Vamvakopoulos, Melpomeni Kountouri, Tom Marshall, et al.
Journal of Vascular Research|January 18, 2006
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosisJoannis E Vamvakopoulos, Lyubomir Petrov, Silja Aavik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
Interleukin 1 and chronic rejection: possible genetic links in human heart allograftsJoannis E Vamvakopoulos, Craig J Taylor, Colin Green, et al.
Pageof 1